European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations

MONITOR-HF is the third randomized, controlled trial globally to show a significant health benefit for indicated heart failure patientsCardioMEMS ...

Related Keywords

Prague ,Praha ,Hlavníesto ,Czech Republic ,Netherlands ,The Netherlands ,Dutch ,Jj Jasper Brugts ,Abbott Cardio ,Philipb Adamson , ,Facebook ,Erasmus University Medical Center ,York Heart Association ,European Society Of Cardiology ,Erasmus Medical Center ,European Society Of Cardiology Heart Failure Association ,National Library Of Medicine ,Dutch Ministry Of Health ,Journal Of The American College Cardiology ,Drug Administration ,Heart Failure Association ,Linkedin ,Agency For Clinical Innovation ,European Society ,Dutch Ministry ,Data Reveal Improved Quality ,Kansas City Cardiomyopathy Questionnaire ,New York Heart Association ,European Conformity ,Important Safety ,Haemodynamic Monitoring ,Pulmonary Artery Pressures ,Chronic Heart ,Cardiology Heart Failure Association ,Optimizing Foundational Therapies ,Foundational Therapies ,Patients With ,American College ,Clinical Trials ,Clinical Care ,Art Review ,Cardiomyopathy Questionnaire ,Kansas City ,